Wateya "Paqij" çi ye?
Heywan mutasyon hilnagire. Wê nexweşî pêş nekeve û wê derbas neke.
Seh Dejenerasyona Pergala Pirjimar a Canine Li Kerry Blue Terrier (CMSD-KBT)
The Canine Multiple System Degeneration (CMSD) DNA test is essential for Kerry Blue Terrier owners to ensure their dogs' health. CMSD is a hereditary neurological disorder affecting coordination and movement in Kerry Blue Terriers. Early genetic testing helps identify carriers and affected dogs, enabling responsible breeding decisions. By using the CMSD DNA test, breeders can reduce the risk of passing this debilitating condition to future generations. This test provides accurate, reliable results, promoting the well-being of your Kerry Blue Terrier. Protect your dog’s health with the CMSD DNA test today. Regular screening supports a healthier, happier canine companion.
Kurtekirin : CMSD-KBT
Mutasyona analîzkirî: SERAC1 c.1536G>A
Mîras: Autosomal Recessive
Acronym
CMSD-KBT
Frequency çavdêrî kirin
Zehmetiya klînîkî
Dabeşkirina klînîkî
Nexweşiyên Neurolojîk
Mutasyona analîz kirin
SERAC1 c.1536G>A
p.(Trp512*)
p.(Trp512*)
Mode mîras
Autosomal Recessive
Kurteya testê:
Canine Multiple System Degeneration (CMSD) is a genetic disorder affecting Kerry Blue Terriers, causing progressive neurological decline. A DNA test is available to identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing can prevent the spread of this debilitating condition within the breed. Responsible breeding practices rely on these genetic insights to maintain healthy Kerry Blue Terrier populations. Overall, the CMSD DNA test is a valuable tool for canine health management.
Ji pakêtê peyda dibe: Basic
Ev testa DNA ji pakêta me dest pê dike tê de ye Basic - û di heman demê de beşek ji pakêtan e Basic, Standard, Advanced, Complete.
Pakêtên testa DNA-ê bibînin →Pakêta ku herî baş li gorî stratejiya weya çandinî an tenduristiya heywanên we tê hilbijêrin.
Understanding Canine Multiple System Degeneration in Kerry Blue Terriers (CMSD-KBT)
Canine Multiple System Degeneration (CMSD) is a progressive neurological disorder that primarily affects Kerry Blue Terriers. This condition is characterized by the degeneration of multiple systems within the nervous system, leading to a range of debilitating symptoms that can significantly impact the quality of life of affected dogs.
Symptoms of CMSD-KBT
The symptoms of CMSD-KBT typically manifest in early to mid-adulthood, although the age of onset can vary. Common signs include balance problems, difficulty walking, and a general lack of coordination. As the disease progresses, affected dogs may exhibit muscle weakness, tremors, and a decline in overall mobility. In some cases, dogs may also experience changes in behavior, such as increased anxiety or a reluctance to engage in normal activities.
Pathophysiology of CMSD-KBT
The underlying cause of CMSD-KBT lies in genetic mutations that affect the nervous system's ability to function properly. These mutations lead to the degeneration of nerve cells, which in turn causes a breakdown of communication between the brain and the body. This disruption results in the clinical symptoms observed in affected dogs. Understanding the genetic basis of CMSD-KBT is crucial for breeders and owners, as it allows for informed decisions regarding breeding practices and the management of affected animals.
Rêvebir û Lênihêrîna ji bo Kûçikên Bibandor
While there is currently no cure for CMSD-KBT, management strategies can help improve the quality of life for affected dogs. Regular veterinary check-ups are essential for monitoring the progression of the disease and addressing any health concerns that arise. Physical therapy and rehabilitation exercises can assist in maintaining mobility and strength. Additionally, providing a safe and supportive environment can help dogs cope with their symptoms and enhance their overall well-being.
Xelasî
Canine Multiple System Degeneration in Kerry Blue Terriers is a serious condition that requires attention from dog owners and breeders. By understanding the symptoms, underlying causes, and management strategies associated with CMSD-KBT, stakeholders can work towards improving the lives of affected dogs while making informed breeding decisions to reduce the prevalence of this condition in the breed.
Nijada ku ji bo ceribandinê tê nas kirin: Dejenerasyona Pergala Pirjimar a Canine Li Kerry Blue Terrier (CMSD-KBT)
- Kerry Blue Terrier
🧬 Interpretation of genotypes CMSD-KBT
Genotype
Cî
🟡 N/N
Non-hilgir - No Risk
🟡 N/CMSD-KBT
Carrier - No Risk
❌ CMSD-KBT/CMSD-KBT
Bi bandor - Di rîskê de
FAQ: têgihiştina şîroveyê
Ma "Carrier" ciddî ye?
Naxêr. Ajal bi gelemperî saxlem e lê dikare mutasyonê bigihîne xwe dûndana.
Heke heywanek "Bê bandor" be?
Ew du kopiyên mutated digire. Nîşanên klînîkî li gorî têne hêvî kirin nexweşî. Divê ew neyê çandin.
Çima di navbera nêr/mê de cudahî hene?
Hin nexweşî bi zayendî ve girêdayî ne, ji ber vê yekê vegotina wan li gorî nexweşiyê diguhere zayenda heywanan.
Pêşbînî Pêşbînî
N/N (ne-hilgir)
N/CMSD-KBT (Barkêş)
CMSD-KBT/CMSD-KBT (Fenî)
FAQ testa DNA
Ev testa DNA-ê çi destnîşan dike?
This DNA test detects the mutation associated with Canine Multiple System Degeneration In Kerry Blue Terrier (CMSD-KBT) in order to identify clear, carrier, or at-risk animals.
Çima heywanek çêdike ceribandin?
Testkirina DNA ji cotkaran re dibe alîkar ku zewacên bi ewletir plansaz bikin û xetera veguheztina mutasyonê ji nifşan re kêm bikin.
Moda mîrasê ya vê testê çi ye?
Moda mîrasê ya ku ji bo vê ceribandinê hatî ragihandin Autosomal Recessive ye.
Di vê testê de kîjan mutasyon tê analîz kirin?
This test analyses the mutation SERAC1 c.1536G>A.
Ma heywanek hilgirê bi neçarî bandor dibe?
Ne hewce ye. Şîrovekirin bi şêwaza mîras û genotipa encam ve girêdayî ye.
Çavkanî
Johnson GS, Mhlanga-Mutangadura T, Morava E, Kozicz T, Taylor JF, O’Brien DP, Schnabel RD. Canine Multiple System Degeneration is Associated with Distinct SERAC1 Mutations in Two Different Dog Breeds [abstract]. Presented at the 63rd Annual Meeting of the American Society of Human Genetics in Boston, Massachusetts; 2013 Oct 22-26.